About the role

Aplyr's Quick Take

This role is for an Associate Director or Director of Clinical Financial Planning & Analysis (FP&A) at BridgeBio Pharma. You'll be responsible for developing financial models and supporting clinical strategy, focusing on budgeting and forecasting for clinical programs. It's a senior-level position that requires both analytical skills and strategic thinking.

Good fit

Ideal candidates have several years of experience in financial planning within the biotech or pharmaceutical sectors, with a strong analytical background. A proactive and innovative mindset will thrive in this fast-paced, problem-solving environment.

Worth noting

The company emphasizes a unique approach to biotech funding and innovation, which may appeal to those looking to work in a less conventional corporate culture. However, the role's specific day-to-day tasks are not clearly defined in the posting.

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
 
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. 
 
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

Who You Are

Reporting to the Executive Director of Portfolio FP&A, the Director – Clinical FP&A will play a critical role in shaping the company's clinical strategy, driving financial planning through insightful analysis, and supporting decision-making processes across the clinical portfolio. This position offers an exciting opportunity to contribute to the growth and success of the Portfolio FP&A team and of BridgeBio

Responsibilities

Financial Strategy & Planning:

Lead the development and management of comprehensive financial models for clinical development programs, including budgeting, forecasting, and long-term financial planning
Serve as the primary finance business partner to leaders across all Clinical Functions
Provide financial insights to inform clinical development strategy, resource allocation, and prioritization of projects
Collaborate across the Clinical organization to define key financial drivers, timelines, and milestones for clinical trials
Develop a suite of metrics and analytics to enable swift scenario analysis and strategic decision support

Budgeting & Forecasting:

Regularly update forecasts to reflect the evolving needs of clinical trials and adjust projections based on actual performance, risk, and opportunity assessments while ensuring all functions are leveraging a “single source of truth.”
Provide key input to NPV and ROI analysis for program decisions and stage gates
Serve as a key member of the team implementing a new clinical trial forecasting & accrual tool for the company

Financial Analysis & Reporting:

Conduct in-depth financial analysis of clinical development costs, evaluating variances and ensuring that financial performance aligns with business objectives
Provide insightful and actionable financial reports to senior leadership, highlighting key trends, risks, and opportunities within the clinical development portfolio
Present financial recommendations to senior management based on data-driven analysis
Develop models and gather data to streamline our “storytelling” and to create internal benchmarks
Skills & Tags
go ai ios data analytics design

Aplyr's read

BridgeBio Pharma is a dynamic biotechnology firm dedicated to tackling genetic diseases and cancers, attracting professionals passionate about impactful medical advancements.
Synthesized from recent postings & public sources

What's promising

•BridgeBio focuses on innovative treatments for genetic diseases, offering significant potential for groundbreaking medical advancements.
•The company has a robust pipeline with multiple late-stage clinical trials, indicating strong future growth prospects.
•BridgeBio's strategic partnerships enhance its research capabilities and expand its therapeutic reach.

What to watch

•The company faces high financial risk due to significant R&D expenditures without guaranteed success.
•BridgeBio operates in a highly competitive market with numerous established players.
•Regulatory hurdles for drug approvals can delay product launches and impact revenue.

Why BridgeBio Pharma

•BridgeBio's focus on genetic diseases and cancers sets it apart in the biotechnology sector.
•The company's decentralized model allows for nimble and efficient project management.
•BridgeBio's commitment to rare diseases addresses unmet medical needs, differentiating its mission.

Aplyr’s read is generated by AI from public sources. Was it useful?